Cortical cerebral metabolism correlates with MRI lesion load and cognitive dysfunction in MS

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Cortical cerebral metabolism correlates with MRI lesion load and cognitive dysfunction in MS. / Blinkenberg, M; Rune, K; Jensen, C V; Ravnborg, M; Kyllingsbaek, S; Holm, S; Paulson, O B; Sørensen, P S.

I: Neurology, Bind 54, Nr. 3, 08.02.2000, s. 558-64.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Blinkenberg, M, Rune, K, Jensen, CV, Ravnborg, M, Kyllingsbaek, S, Holm, S, Paulson, OB & Sørensen, PS 2000, 'Cortical cerebral metabolism correlates with MRI lesion load and cognitive dysfunction in MS', Neurology, bind 54, nr. 3, s. 558-64. https://doi.org/10.1212/wnl.54.3.558

APA

Blinkenberg, M., Rune, K., Jensen, C. V., Ravnborg, M., Kyllingsbaek, S., Holm, S., Paulson, O. B., & Sørensen, P. S. (2000). Cortical cerebral metabolism correlates with MRI lesion load and cognitive dysfunction in MS. Neurology, 54(3), 558-64. https://doi.org/10.1212/wnl.54.3.558

Vancouver

Blinkenberg M, Rune K, Jensen CV, Ravnborg M, Kyllingsbaek S, Holm S o.a. Cortical cerebral metabolism correlates with MRI lesion load and cognitive dysfunction in MS. Neurology. 2000 feb. 8;54(3):558-64. https://doi.org/10.1212/wnl.54.3.558

Author

Blinkenberg, M ; Rune, K ; Jensen, C V ; Ravnborg, M ; Kyllingsbaek, S ; Holm, S ; Paulson, O B ; Sørensen, P S. / Cortical cerebral metabolism correlates with MRI lesion load and cognitive dysfunction in MS. I: Neurology. 2000 ; Bind 54, Nr. 3. s. 558-64.

Bibtex

@article{e8a3d7e1919f4fda8b8318fbe92e81b5,
title = "Cortical cerebral metabolism correlates with MRI lesion load and cognitive dysfunction in MS",
abstract = "OBJECTIVE: To study the association between the cortical cerebral metabolic rate of glucose (CMRglc), MRI T2-weighted total lesion area (TLA), cognitive dysfunction, and neurologic disability in MS.BACKGROUND: MRI lesion load is widely used in the clinical evaluation of the MS patient but little is known about the associated changes in cortical activation.METHODS: Twenty-three patients with clinically definite MS underwent measurements of CMRglc, TLA, motor evoked potentials (MEPs), and cognitive and neurologic disability. CMRglc was calculated using PET and 18-F-deoxyglucose and compared with nine normal control subjects.RESULTS: Reductions in CMRglc (p < 0.01) were found in the cortical global and regional lobar measurements. Furthermore, regional CMRglc (rCMRglc) was reduced in the dorsolateral prefrontal cortex, orbitofrontal cortex, caudate, putamen, thalamus, and hippocampus. Global cortical CMRglc correlated with TLA (Spearman rank correlation coefficient [SRCC] = -0.66, p = 0.001), and rCMRglc correlated with regional lesion load in all cerebral lobes (p < or = 0.05). Global cortical CMRglc and cognitive disability also correlated (SRCC = 0.58, p = 0.015), and stepwise regression analysis showed a significant association between rCMRglc of the right thalamus and cognitive performance as well as TLA. There was no correlation between CMRglc and neurologic disability (Expanded Disability Status Scale) or MEP.CONCLUSION: Global and regional cortical CMRglc is reduced significantly in MS patients compared with normal control subjects. Furthermore, the CMRglc reductions correlate with TLA as well as with cognitive dysfunction, which indicates that MRI white matter lesion burden has a deteriorating effect on cortical cerebral neural function.",
keywords = "Adult, Aged, Brain/diagnostic imaging, Cognition Disorders/pathology, Female, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Multiple Sclerosis/diagnostic imaging, Neuropsychological Tests, Tomography, Emission-Computed",
author = "M Blinkenberg and K Rune and Jensen, {C V} and M Ravnborg and S Kyllingsbaek and S Holm and Paulson, {O B} and S{\o}rensen, {P S}",
year = "2000",
month = feb,
day = "8",
doi = "10.1212/wnl.54.3.558",
language = "English",
volume = "54",
pages = "558--64",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams & Wilkins",
number = "3",

}

RIS

TY - JOUR

T1 - Cortical cerebral metabolism correlates with MRI lesion load and cognitive dysfunction in MS

AU - Blinkenberg, M

AU - Rune, K

AU - Jensen, C V

AU - Ravnborg, M

AU - Kyllingsbaek, S

AU - Holm, S

AU - Paulson, O B

AU - Sørensen, P S

PY - 2000/2/8

Y1 - 2000/2/8

N2 - OBJECTIVE: To study the association between the cortical cerebral metabolic rate of glucose (CMRglc), MRI T2-weighted total lesion area (TLA), cognitive dysfunction, and neurologic disability in MS.BACKGROUND: MRI lesion load is widely used in the clinical evaluation of the MS patient but little is known about the associated changes in cortical activation.METHODS: Twenty-three patients with clinically definite MS underwent measurements of CMRglc, TLA, motor evoked potentials (MEPs), and cognitive and neurologic disability. CMRglc was calculated using PET and 18-F-deoxyglucose and compared with nine normal control subjects.RESULTS: Reductions in CMRglc (p < 0.01) were found in the cortical global and regional lobar measurements. Furthermore, regional CMRglc (rCMRglc) was reduced in the dorsolateral prefrontal cortex, orbitofrontal cortex, caudate, putamen, thalamus, and hippocampus. Global cortical CMRglc correlated with TLA (Spearman rank correlation coefficient [SRCC] = -0.66, p = 0.001), and rCMRglc correlated with regional lesion load in all cerebral lobes (p < or = 0.05). Global cortical CMRglc and cognitive disability also correlated (SRCC = 0.58, p = 0.015), and stepwise regression analysis showed a significant association between rCMRglc of the right thalamus and cognitive performance as well as TLA. There was no correlation between CMRglc and neurologic disability (Expanded Disability Status Scale) or MEP.CONCLUSION: Global and regional cortical CMRglc is reduced significantly in MS patients compared with normal control subjects. Furthermore, the CMRglc reductions correlate with TLA as well as with cognitive dysfunction, which indicates that MRI white matter lesion burden has a deteriorating effect on cortical cerebral neural function.

AB - OBJECTIVE: To study the association between the cortical cerebral metabolic rate of glucose (CMRglc), MRI T2-weighted total lesion area (TLA), cognitive dysfunction, and neurologic disability in MS.BACKGROUND: MRI lesion load is widely used in the clinical evaluation of the MS patient but little is known about the associated changes in cortical activation.METHODS: Twenty-three patients with clinically definite MS underwent measurements of CMRglc, TLA, motor evoked potentials (MEPs), and cognitive and neurologic disability. CMRglc was calculated using PET and 18-F-deoxyglucose and compared with nine normal control subjects.RESULTS: Reductions in CMRglc (p < 0.01) were found in the cortical global and regional lobar measurements. Furthermore, regional CMRglc (rCMRglc) was reduced in the dorsolateral prefrontal cortex, orbitofrontal cortex, caudate, putamen, thalamus, and hippocampus. Global cortical CMRglc correlated with TLA (Spearman rank correlation coefficient [SRCC] = -0.66, p = 0.001), and rCMRglc correlated with regional lesion load in all cerebral lobes (p < or = 0.05). Global cortical CMRglc and cognitive disability also correlated (SRCC = 0.58, p = 0.015), and stepwise regression analysis showed a significant association between rCMRglc of the right thalamus and cognitive performance as well as TLA. There was no correlation between CMRglc and neurologic disability (Expanded Disability Status Scale) or MEP.CONCLUSION: Global and regional cortical CMRglc is reduced significantly in MS patients compared with normal control subjects. Furthermore, the CMRglc reductions correlate with TLA as well as with cognitive dysfunction, which indicates that MRI white matter lesion burden has a deteriorating effect on cortical cerebral neural function.

KW - Adult

KW - Aged

KW - Brain/diagnostic imaging

KW - Cognition Disorders/pathology

KW - Female

KW - Humans

KW - Magnetic Resonance Imaging

KW - Male

KW - Middle Aged

KW - Multiple Sclerosis/diagnostic imaging

KW - Neuropsychological Tests

KW - Tomography, Emission-Computed

U2 - 10.1212/wnl.54.3.558

DO - 10.1212/wnl.54.3.558

M3 - Journal article

C2 - 10680783

VL - 54

SP - 558

EP - 564

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 3

ER -

ID: 260897555